AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Long-Term Epilepsy Outcomes in Children With a History of Perinatal Stroke

Recruitingn/aAges 5 Years - 25 YearsAllUniversity Hospital, Strasbourg, France
💬

In plain words

What the trial is, and whether it could suit you

Perinatal stroke is a rare condition affecting approximately 20-40 births per 100,000. It may be ischemic or hemorrhagic and can occur before or around birth, with diagnosis sometimes delayed until motor or cognitive symptoms emerge. Potential long-term consequences include motor deficits, cognitive and learning difficulties, language disorders, and epilepsy. Post-stroke epilepsy is estimated to affect approximately 30% of children who experience perinatal stroke. Although neonatal outcomes are relatively well characterized, the long-term course of epilepsy in this population and the relationship between initial stroke characteristics and subsequent epilepsy outcomes remain insufficiently studied. The primary objective of this retrospective, multicenter, observational study is to characterize the long-term course of epilepsy in children who experienced an ischemic or hemorrhagic stroke

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Minors aged 5 to under 18 years or adults aged 18 to 25 years. * Patients who attended one of the two participating centers: Strasbourg University Hospitals or Necker Hospital (AP-HP). * Confirmed or suspected ischemic or hemorrhagic stroke occurring before 28 days of age. * During follow-up, presentation of criteria for focal epilepsy, infantile spasms, continuous spike-and-wave during sleep (CSWS), or Lennox-Gastaut syndrome. Exclusion Criteria: * Birth before 34 weeks of gestation. * Birth weight below 1,500 g. * Perinatal hypoxic-ischemic injury with residual MRI lesions. * Insufficient information in medical records. * Refusal to participate in the study.
💊

What it tests

  • Not listed
📍

Where

1 site
Service de Pédiatrie 1 - Hôpital de Hautepierre - CHU de Strasbourg, France
Strasbourg, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy